Cranbrook Wealth Management’s Clorox CLX Stock Holding History

Cranbrook Wealth Management’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-16	Closed	-$3K	–	355
2021 Q1	$3K	Buy	+16	New	+$3.08K	﹤0.01%	337

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cranbrook Wealth Management's CLX Position: Q2 2021 in Review

Cranbrook Wealth Management sold out of Clorox (CLX) in Q2 2021, closing a stake of 16 shares — an estimated $3K sold.

Cranbrook Wealth Management first reported a position in CLX in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 1,168 funds tracked by Wall St. Rank hold CLX as of Q2 2021.

Cranbrook Wealth Management reported no remaining Clorox position as of Q2 2021 after selling out during the quarter.
Cranbrook Wealth Management sold 16 Clorox shares in Q2 2021, an estimated $3K.
Cranbrook Wealth Management first reported a position in Clorox in Q1 2021 and held it in 1 quarter.
Cranbrook Wealth Management's Clorox position peaked at $3K in Q1 2021.
1,168 funds tracked by Wall St. Rank held Clorox as of Q2 2021.

Based on Cranbrook Wealth Management's 13F filing for Q2 2021, filed 12 Aug 2021.